Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Meden

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Journal of Electrocardiology|October 9, 2001
The effect of estrogen replacement therapy on ventricular repolarization dynamics in healthy postmenopausal womenB Vrtovec, V Starc, H Meden-Vrtovec
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 29, 2007
Metabolic and cardiovascular changes in women with polycystic ovary syndromeH Meden-Vrtovec, B Vrtovec, J Osredkar
Methods in Molecular Medicine|February 23, 2011
ELISA-Based Quantification of p105 (c-erbB-2, HER2/neu) in Serum of Ovarian CarcinomaH Meden, A Fattahi-Meibodi, D Marx
Clinical and Experimental Obstetrics & Gynecology|February 24, 2001
Infertility treatment by in vitro fertilization in patients with minimal or mild endometriosisH Meden-Vrtovec, T Tomazevic, I Verdenik
Human Reproduction (Oxford, England)|September 1, 1994
The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programmeK Gersak, H Meden-Vrtovec, T Tomazevic
Zentralblatt Fur Gynakologie|September 16, 1999
[Efficiency, safety and tolerability of recombinant human interleukin-3 (rhIL-3) as supportive therapy accompanying dose-intensive carboplatin containing chemotherapy in ovarian cancer with special regard to thrombocytopenia]H Meden, M Fock, T Krauss, et al.
Journal of Assisted Reproduction and Genetics|January 13, 2001
The future law on infertility treatment and on biomedically assisted procreation in SloveniaK Zupancic, H Meden, T Tomazevic, et al.
In Vivo (Athens, Greece)|January 1, 1997
Serum levels of the c-erbB-2 (HER2/neu) encoded oncoprotein fragment p105 in normal pregnanciesH Meden, S Mielke, A Schauer, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|November 1, 1996
[Obstetric aspects of maternal hepatitis C infection]S Herzog, H Meden, K Harms, et al.
Onkologie|October 1, 1989
[Serum level of the tumor marker CA 125 before second-look laparatomy in primary epithelial ovarian cancer in relation to intraoperative findings]H Meden, W Rath, A Teichmann, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Journal of Electrocardiology|October 9, 2001
The effect of estrogen replacement therapy on ventricular repolarization dynamics in healthy postmenopausal womenB Vrtovec, V Starc, H Meden-Vrtovec
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 29, 2007
Metabolic and cardiovascular changes in women with polycystic ovary syndromeH Meden-Vrtovec, B Vrtovec, J Osredkar
Methods in Molecular Medicine|February 23, 2011
ELISA-Based Quantification of p105 (c-erbB-2, HER2/neu) in Serum of Ovarian CarcinomaH Meden, A Fattahi-Meibodi, D Marx
Clinical and Experimental Obstetrics & Gynecology|February 24, 2001
Infertility treatment by in vitro fertilization in patients with minimal or mild endometriosisH Meden-Vrtovec, T Tomazevic, I Verdenik
Human Reproduction (Oxford, England)|September 1, 1994
The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programmeK Gersak, H Meden-Vrtovec, T Tomazevic
Zentralblatt Fur Gynakologie|September 16, 1999
[Efficiency, safety and tolerability of recombinant human interleukin-3 (rhIL-3) as supportive therapy accompanying dose-intensive carboplatin containing chemotherapy in ovarian cancer with special regard to thrombocytopenia]H Meden, M Fock, T Krauss, et al.
Journal of Assisted Reproduction and Genetics|January 13, 2001
The future law on infertility treatment and on biomedically assisted procreation in SloveniaK Zupancic, H Meden, T Tomazevic, et al.
In Vivo (Athens, Greece)|January 1, 1997
Serum levels of the c-erbB-2 (HER2/neu) encoded oncoprotein fragment p105 in normal pregnanciesH Meden, S Mielke, A Schauer, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|November 1, 1996
[Obstetric aspects of maternal hepatitis C infection]S Herzog, H Meden, K Harms, et al.
Onkologie|October 1, 1989
[Serum level of the tumor marker CA 125 before second-look laparatomy in primary epithelial ovarian cancer in relation to intraoperative findings]H Meden, W Rath, A Teichmann, et al.
Pageof 11